News
The U.S. Food and Drug Administration has cracked down on compounded drugs, which were readily available while the patented ...
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...
After years of easily available, cheap copies of Eli Lilly's and Novo Nordisk's highly effective weight-loss drugs, some U.S.
Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...
Eli Lilly (NYSE:LLY) witnessed a modest 1.31% increase in its share price over the past week, coinciding with the Australian ...
Investing.com -- Cigna’s Evernorth has introduced a new pharmacy benefit that caps out-of-pocket costs for GLP-1 weight loss ...
The agreements cap monthly out-of-pocket costs for Zepbound and Wegovy at $200 and more deeply discount the drugs for ...
How a new Trump plan could make science ‘a political football’ The NIH is already in turmoil. Billlions of dol ...
Successful trial results in the next few years could save thousands of lives and generate billions in new annual revenue for ...
Donanemab is only for use in the early stages of Alzheimer’s disease. And for now at least, it comes with a hefty price tag.
12hon MSN
The Cigna Group (NYSE: CI )’s Evernorth division has announced a new deal with Novo Nordisk and Eli Lilly that will limit ...
The U.S. Food and Drug Administration has cracked down on compounded drugs, which were readily available while the patented ones were in shortage, and many are worried they will lose access to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results